Loading…
Tyra Biosciences, Inc. is projected to rise to $38.23 by 2027, a +17% move from its current price of $32.75. TYRA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $31.87 | $32.77 | $33.69 | +0.05% |
| Jul 14 | $31.52 | $32.78 | $34.09 | +0.09% |
| Jul 15 | $31.26 | $32.80 | $34.41 | +0.14% |
| Jul 16 | $31.04 | $32.81 | $34.68 | +0.19% |
| Jul 17 | $30.85 | $32.83 | $34.93 | +0.23% |
| Jul 18 | $30.69 | $32.84 | $35.15 | +0.28% |
| Jul 19 | $30.53 | $32.86 | $35.36 | +0.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $30.53 | $32.86 | $35.36 | +0.33% |
| Week 2 | $29.72 | $32.96 | $36.57 | +0.65% |
| Week 3 | $29.13 | $33.07 | $37.55 | +0.98% |
| Week 4 | $28.65 | $33.18 | $38.42 | +1.31% |
| Week 5 | $28.25 | $33.29 | $39.22 | +1.64% |
| Week 6 | $27.91 | $33.40 | $39.97 | +1.97% |
| Week 7 | $27.60 | $33.51 | $40.68 | +2.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on precision medicines for FGFR biology in the United States. It offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and FGFR3.
Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for intrahepatic cholangiocarcinoma; and TYRA-430 for the treatment of hepatocellular carcinoma. Tyra Biosciences, Inc.
was incorporated in 2018 and is headquartered in Carlsbad, California.
Tyra Biosciences, Inc. (TYRA) operates in the healthcare sector as a clinical-stage biotechnology company focused on FGFR biology and precision medicines. The stock trades at $30.94 per share and has a market capitalization of $1.84B. It is ranked 2093.
A major floor 31.2% below — a decisive break under it would weaken the trend.
The nearest floor, 22.4% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 20.9% above — clearing it would confirm fresh momentum.
Key TYRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TYRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $32.23 | Buy | $32.31 | Buy |
| MA 10 | $31.71 | Buy | $31.67 | Buy |
| MA 20 | $30.27 | Buy | $31.03 | Buy |
| MA 50 | $31.55 | Buy | $31.47 | Buy |
| MA 100 | $33.55 | Sell | $31.18 | Buy |
| MA 200 | $27.50 | Buy | $27.92 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.69 | Neutral |
| Stoch RSI (14) | 90.10 | Sell |
| CCI (20) | 103.07 | Buy |
| Williams %R (14) | -7.22 | Info |
| MACD (12,26,9) | 0.46 | Buy |
| ROC (12) | 8.95 | Buy |
| Bollinger %B (20,2) | 0.82 | Neutral |
| Stochastic %K (14) | 92.78 | Sell |
| TRIX (15) | -0.01 | Sell |
| Awesome (5,34) | 2.13 | Buy |
| Ultimate (7,14,28) | 59.45 | Neutral |
| Momentum (10) | 1.81 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 33.14 | Sell |
| ADX (14) | 16.08 | Neutral |
| ATR (14) | 0.77 | Info |
From a technical view, the near-term outlook is bullish. RSI (14) sits at 50, and the 50-day simple moving average is $32.41 while the 200-day simple moving average is $26.54, signaling a constructive setup with price supported above the longer-term trend. A clear near-term floor and ceiling are $25.42 and $37.04, respectively.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $25.42 | $32.75 | $43.37 | 0% | Neutral | |
| $30.39 | $38.23 | $50.90 | +17% | Neutral | |
| $32.54 | $42.11 | $58.21 | +29% | Bullish | |
| $36.53 | $48.39 | $68.87 | +48% | Bullish | |
| $41.71 | $56.42 | $82.30 | +72% | Bullish | |
| $49.14 | $67.73 | $100.95 | +107% | Bullish | |
| $57.94 | $81.29 | $123.51 | +148% | Bullish | |
| $59.78 | $85.27 | $131.84 | +160% | Bullish | |
| $61.19 | $88.67 | $139.31 | +171% | Bullish | |
| $65.32 | $96.09 | $153.24 | +193% | Bullish | |
| $104.55 | $164.67 | $279.50 | +403% | Bullish | |
| $164.40 | $291.34 | $541.53 | +790% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $25.42 | $32.75 | $40.05 | +0.00% |
| August 2026 | $29.31 | $34.61 | $41.97 | +5.67% |
| September 2026 | $28.74 | $34.17 | $41.91 | -1.27% |
| October 2026 | $28.38 | $33.96 | $42.04 | -0.62% |
| November 2026 | $28.87 | $34.72 | $43.33 | +2.24% |
| December 2026 | $28.55 | $34.50 | $43.37 | -0.63% |
Click any year to see its month-by-month TYRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect TYRA to range from $25.42 to $43.37 through 2026. The $32.75 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The TYRA price prediction for 2027 points to an average of $38.23 (low $30.39, high $50.90) — a potential gain of +17% on today's $32.75. Price action looks broadly range-bound.
In 2028, TYRA is projected to trade between $32.54 and $58.21, averaging $42.11 — a potential gain of +29% from today's $32.75. That is up +10% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Tyra Biosciences, Inc.'s 2029 outlook centres on $48.39, within a $36.53 to $68.87 range. That is up +15% on the projected 2028 average. That marks a +48% change versus current levels. Momentum favours further upside here.
By 2030, TYRA could reach as high as $82.30, with a base case around $56.42 and support toward $41.71 — roughly +72% from $32.75. Buyers look set to stay in control over this stretch.
Expect TYRA to range from $49.14 to $100.95 through 2031. The $67.73 average target implies a +107% move from current prices. That is up +20% on the projected 2030 average. Momentum favours further upside here.
The TYRA price prediction for 2032 points to an average of $81.29 (low $57.94, high $123.51) — a potential gain of +148% on today's $32.75. Buyers look set to stay in control over this stretch.
In 2033, TYRA is projected to trade between $59.78 and $131.84, averaging $85.27 — a potential gain of +160% from today's $32.75. That is up +5% on the projected 2032 average. Momentum favours further upside here.
Tyra Biosciences, Inc.'s 2034 outlook centres on $88.67, within a $61.19 to $139.31 range. That is up +4% on the projected 2033 average. That marks a +171% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, TYRA could reach as high as $153.24, with a base case around $96.09 and support toward $65.32 — roughly +193% from $32.75. Momentum favours further upside here.
Expect TYRA to range from $104.55 to $279.50 through 2040. The $164.67 average target implies a +403% move from current prices. That is up +71% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The TYRA price prediction for 2050 points to an average of $291.34 (low $164.40, high $541.53) — a potential gain of +790% on today's $32.75. Momentum favours further upside here.
Investing $1,000 in TYRA today (≈ 30.534351 TYRA) could be worth
$8,895.83
+$7,895.83 (+790%) by 2050 · US Dollar
Based on the average projected TYRA price of $291.34 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TYRAwould be worth at today's price.
$1,000 invested in TYRA on Jul 10, 2025 (≈ 97.656252 TYRA) would be worth
$3,198.24
+$2,198.24 (+219.8%) today · 3.20× · US Dollar
Based on a TYRA entry price of $10.24 vs. today's $32.75.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $30.62 | $1,069.56 | +7.0% |
| 1 month ago | $25.42 | $1,288.36 | +28.8% |
| 3 months ago | $35.26 | $928.81 | -7.1% |
| 6 months ago | $28.77 | $1,138.34 | +13.8% |
| 1 year ago | $10.24 | $3,198.24 | +219.8% |
| All time (4.8y) ago | $26 | $1,259.62 | +26.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TYRA forecast.
Our base-case forecast reaches $66.00 around 2031.
Implied market cap at $66.00: $3.93B
The multi-year forecast shows meaningful upside. In 2026, the average price is $30.94 with a min of $25.42 and a max of $40.77, and a 0% ROI, with a Neutral sentiment. By 2030, the average price rises to $58.07 and the max to $85.32, yielding an 87.7% ROI with a Bullish sentiment.
By 2040, the average price is $180.32 and the max $309.15, for a 482.8% ROI and Bullish sentiment. In 2050, the average price reaches $317.83 with a max of $597.70, delivering a 927.3% ROI and Bullish sentiment. These figures illustrate substantial long-term upside potential, alongside the inherent uncertainty and the need to recognize that these are estimates, not guarantees.
The forecast also shows continued bullish momentum beyond 2030, reflecting expectations of growth through extended horizons.
Tap a question to reveal the answer.
In 2030, the forecast shows a min of $42.66, an average of $58.07, and a max of $85.32, with a ROI of 87.7% and a Bullish sentiment.
The forecast indicates a bullish sentiment from 2027 onward, with the average price rising to $58.07 by 2030, $180.32 by 2040, and $317.83 by 2050, and ROI reaching 87.7% in 2030 and 927.3% in 2050.
Yes. The 2035 forecast shows a min of $67.17, an average of $99.71, and a max of $160.43, placing the average near $100 and the potential to surpass it within the forecast window.
For 2040, the forecast lists a min of $113.13, an average of $180.32, and a max of $309.15, with a 482.8% ROI and Bullish sentiment.
In 2050, the forecast shows a min of $176.32, an average of $317.83, and a max of $597.70, with a 927.3% ROI and Bullish sentiment.
Tyra Biosciences, Inc. Community Discussion
0Share your Tyra Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.